APA

Romieu-Mourez R., François M., Abate A., Boivin M., Birman E., Bailey D., Bramson J. L., Forner K., Young Y., Medin J. A. & Galipeau J. (20101123). Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming. : Cancer research.

Chicago

Romieu-Mourez Raphaëlle, François Moïra, Abate Amanda, Boivin Marie-Noëlle, Birman Elena, Bailey Dana, Bramson Jonathan L, Forner Kathy, Young Yoon-Kow, Medin Jeffrey A and Galipeau Jacques. 20101123. Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming. : Cancer research.

Harvard

Romieu-Mourez R., François M., Abate A., Boivin M., Birman E., Bailey D., Bramson J. L., Forner K., Young Y., Medin J. A. and Galipeau J. (20101123). Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming. : Cancer research.

MLA

Romieu-Mourez Raphaëlle, François Moïra, Abate Amanda, Boivin Marie-Noëlle, Birman Elena, Bailey Dana, Bramson Jonathan L, Forner Kathy, Young Yoon-Kow, Medin Jeffrey A and Galipeau Jacques. Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming. : Cancer research. 20101123.